本文指出当前中国药品安全监管中存在的“单一治理模式”难以应对出现的诸多新问题,论述了药品安全从“监管模式”向“治理模式”转型的必要性,同时,介绍了国内外“独立第三方”参与行业治理的法律制度设计和做法,提出了培育“独立第三方”参与我国药品安全治理的制度设计、主要形式和发展目标等建议。
<<This paper points out that “single governance model” existing in the current China's drug safety regulation cannot deal with many new problems arisen,discusses the necessity of transformation on drug safety from “supervision model” to “governance model”,and introduces the legal system design and practice of “independent third party” to participate in industry governance at home and abroad,as well as comes up with system design,primary form,development goals and other suggestions in cultivating the “independent third party” to participate in Chinese drug security governance.
<<Keywords: | Single Governance ModelMultiple Governance ModelIndependent Third PartyDrug Security Governance Model |